InvestorsHub Logo
Followers 41
Posts 5379
Boards Moderated 0
Alias Born 11/15/2013

Re: jav0033 post# 413952

Friday, 05/05/2023 2:46:55 PM

Friday, May 05, 2023 2:46:55 PM

Post# of 460102
ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,

SHOWING STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN GLOBAL CLINICAL STUDY OF PATIENTS WITH EARLY ALZHEIMER’S DISEASE

What data/numbers are you looking for.

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News